Wingtech sues Nexperia for €1bn

Wingtech Technology has opened a new front in its fight over Dutch chipmaker Nexperia, filing suit in China for at least 8 billion yuan, or about €1 billion, in damages. The case turns a corporate control dispute into a test of how far China’s Anti-Foreign Sanctions Law can be used against actions tied to a European government intervention. Reuters, Bloomberg and the South China Morning Post reported that Wingtech says restrictions on its control of Nexperia caused economic losses and should be unwound. ### Who is suing whom, and for how much? Wingtech said in a stock-exchange filing reported on May 23 that it had sued Nexperia and five other entities in the Dongguan Intermediate People’s Court. Reuters reported the company was provisionally seeking 8 billion yuan, about $1.18 billion, for economic losses tied to what it said were continuing limits on its control of the Dutch chipmaker. (asia.nikkei.com) Bloomberg reported that Wingtech is also seeking restoration of control over its Dutch unit. The South China Morning Post said the suit named Nexperia and three executives and framed their actions as “discriminatory restrictive measures.” ### Why is control of Nexperia in dispute? Nexperia is a Dutch semiconductor company that became part of Wingtech’s corporate structure after Wingtech bought the business from Beijing Jianguang Asset Management in 2021, according to prior public reporting. (asia.nikkei.com) The latest lawsuit follows Dutch intervention in Nexperia’s governance, which Reuters and other outlets have linked to concerns in The Hague over the company’s direction, supply security and the possible transfer of operations or intellectual property out of Europe. (bloomberg.com) Reuters reported in October 2025 that the Dutch government had taken control of Nexperia in a rare move. That intervention came after a standoff between China and the Netherlands and followed Dutch concerns that the company’s European operations could be hollowed out, according to Reuters reporting cited by third-party syndication pages surfaced in search. (marketscreener.com) ### Why does China’s Anti-Foreign Sanctions Law matter here? Wingtech’s filing argues that the restrictions on its control amount to foreign discriminatory measures and that Chinese law gives it a basis to seek compensation. Reuters said the company explicitly tied its claim to China’s Anti-Foreign Sanctions Law, while the South China Morning Post said Wingtech accused Nexperia and its executives of carrying out restrictive measures under that framework. (marketscreener.com) That matters because the law was designed as a response tool to foreign sanctions and restrictions. In this case, Wingtech appears to be using it in a commercial dispute linked to state action abroad. That is an inference from the company’s legal framing and the reported facts, not a characterization offered in the same terms by the sources. ### Is this the only case tied to the Nexperia fight? (asia.nikkei.com) No. Reuters reported that in January Wingtech sought international arbitration and pursued damages of up to $8 billion. The new China lawsuit is therefore one piece of a broader legal campaign rather than a standalone claim. Nikkei Asia, citing Reuters, reported the latest case as part of an escalating battle over control. (asia.nikkei.com) Bloomberg described the filing as the latest step after Dutch measures and court rulings restricted Wingtech’s authority over the business. ### What happens next? The Dongguan Intermediate People’s Court has accepted the case, according to Wingtech’s filing as reported by Reuters and other outlets. (wifc.com) That means the dispute now runs on at least two tracks: Chinese court proceedings and other international claims Wingtech has already launched. Nexperia’s response, any court timetable in Dongguan, and the status of the separate arbitration claim are the next concrete markers to watch. (asia.nikkei.com) As of the May 23 reports, the immediate public record centered on Wingtech’s filing, the 8 billion yuan damages request, and its demand to reverse restrictions on control.